tiprankstipranks
Trending News
More News >
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market

Keros Therapeutics (KROS) Income Statement

Compare
357 Followers

Keros Therapeutics Income Statement

Last quarter (Q3 2025), Keros Therapeutics's total revenue was $14.26M, an increase of 3575.77% from the same quarter last year. In Q3, Keros Therapeutics's net income was $-7.28M. See Keros Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 3.55M$ 151.00K$ 0.00$ 20.10M$ 0.00
Gross Profit
$ 3.55M$ 151.00K$ 0.00$ 20.10M$ -605.00K
Operating Expenses
$ 214.38M$ 170.09M$ 114.79M$ 76.47M$ 46.05M
Depreciation and Amortization
$ 1.23M$ 815.00K$ 674.00K$ 378.00K$ 605.00K
EBITDA
$ -185.82M$ -152.18M$ -104.00M$ -56.35M$ -44.92M
Operating Income
$ -210.83M$ -169.94M$ -114.79M$ -56.37M$ -46.66M
Other Income/Expenses
$ 23.78M$ 16.95M$ 10.11M$ -360.00K$ 1.12M
Pretax Income
$ -187.05M$ -152.99M$ -104.68M$ -56.73M$ -45.53M
Net Income
$ -187.35M$ -152.99M$ -104.68M$ -58.74M$ -45.36M
Per Share Metrics
Basic EPS
$ -5.00$ -5.20$ -4.15$ -2.52$ -2.93
Diluted EPS
$ -5.00$ -5.20$ -4.15$ -2.52$ -2.93
Weighted Average Shares Outstanding
37.44M 29.45M 25.24M 23.33M 15.51M
Weighted Average Shares Outstanding (Diluted)
37.44M 29.45M 25.24M 23.33M 15.51M
Currency in USD

Keros Therapeutics Earnings and Revenue History